Skip to content
← Back to this collection

PUBLICATIONS · 29226797

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2017 Dec 28
First author
Neelapu SS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2017 Dec 28;377(26):2593-2596. doi: 10.1056/NEJMe1714680.
    note
    Source null
    related pmid
    29226781
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2018 Feb;15(2):65. doi: 10.1038/nrclinonc.2017.208.
    note
    Source null
    related pmid
    29297506
    relationship
    Comment in
  3. citation
    N Engl J Med. 2018 Mar 15;378(11):1065. doi: 10.1056/NEJMc1800913.
    note
    Source null
    related pmid
    29542306
    relationship
    Comment in
  4. citation
    Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1396-1399. doi: 10.1016/j.ijrobp.2018.05.079.
    note
    Source null
    related pmid
    31014778
    relationship
    Comment in

Authors and identifiers

  1. name
    Neelapu SS
    type
    Author
  2. name
    Locke FL
    type
    Author
  3. name
    Bartlett NL
    type
    Author
  4. name
    Lekakis LJ
    type
    Author
  5. name
    Miklos DB
    type
    Author
  6. name
    Jacobson CA
    type
    Author
  7. name
    Braunschweig I
    type
    Author
  8. name
    Oluwole OO
    type
    Author
  9. name
    Siddiqi T
    type
    Author
  10. name
    Lin Y
    type
    Author
  11. name
    Timmerman JM
    type
    Author
  12. name
    Stiff PJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Neelapu SS
    type
    Author
  2. name
    Locke FL
    type
    Author
  3. name
    Bartlett NL
    type
    Author
  4. name
    Lekakis LJ
    type
    Author
  5. name
    Miklos DB
    type
    Author
  6. name
    Jacobson CA
    type
    Author
  7. name
    Braunschweig I
    type
    Author
  8. name
    Oluwole OO
    type
    Author
  9. name
    Siddiqi T
    type
    Author
  10. name
    Lin Y
    type
    Author
  11. name
    Timmerman JM
    type
    Author
  12. name
    Stiff PJ
    type
    Author
bibliography ids
  1. nci-bib-5ae95790d0ade7d73f7a9f97
book metadata
content sha256
526bddd96ff6c4a03bacdd6047f41fdbbd8f2f0c46347ff2c1cf81ea2edbfd0c
document type
citation
dois
  1. 10.1056/NEJMoa1707447
electronic publication date
display
2017 Dec 10
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:29226797
immutable id
pubmed:29226797@526bddd96ff6c4a03bacdd6047f41fdbbd8f2f0c46347ff2c1cf81ea2edbfd0c
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
26
name
The New England journal of medicine
nlm unique id
0255562
pages
2531-2544
volume
377
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2017 Dec 28;377(26):2593-2596. doi: 10.1056/NEJMe1714680.
    note
    Source null
    related pmid
    29226781
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2018 Feb;15(2):65. doi: 10.1038/nrclinonc.2017.208.
    note
    Source null
    related pmid
    29297506
    relationship
    Comment in
  3. citation
    N Engl J Med. 2018 Mar 15;378(11):1065. doi: 10.1056/NEJMc1800913.
    note
    Source null
    related pmid
    29542306
    relationship
    Comment in
  4. citation
    Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1396-1399. doi: 10.1016/j.ijrobp.2018.05.079.
    note
    Source null
    related pmid
    31014778
    relationship
    Comment in
outcomes validated
false
pmid
29226797
provenance
batch id
ec9444d0f4cade22eb9f
provider
NCBI PubMed ESummary
record sha256
6293c8ba989f0f41701ad0752ee1de275f240b69c8c8ab434b5806af544cb07b
response sha256
6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
retrieved at
2026-09-09T23:47:30.975610+00:00
publication date
display
2017 Dec 28
precision
day
year
2017
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29226797/
title
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

Preserved source evidence · Independent clinical review pending · Not medical advice